During the last session, AEON Biopharma Inc (AMEX:AEON)’s traded shares were 1.0 million, with the beta value of the company hitting 0.61. At the end of the trading day, the stock’s price was $0.62, reflecting an intraday gain of 1.98% or $0.01. The 52-week high for the AEON share is $269.28, that puts it down -43332.26 from that peak though still a striking 38.71% gain since the share price plummeted to a 52-week low of $0.38. The company’s market capitalization is $7.00M, and the average trade volume was 3.60 million shares over the past three months.
AEON Biopharma Inc (AEON) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. AEON has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it.
AEON Biopharma Inc (AMEX:AEON) trade information
AEON Biopharma Inc (AEON) registered a 1.98% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 1.98% in intraday trading to $0.62, hitting a weekly high. The stock’s 5-day price performance is 21.68%, and it has moved by 47.38% in 30 days. Based on these gigs, the overall price performance for the year is -99.57%.
AEON Dividends
AEON Biopharma Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
AEON Biopharma Inc (AMEX:AEON)’s Major holders
Also, the Mutual Funds coming in first place with the largest holdings of AEON Biopharma Inc (AEON) shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund. Data provided on Mar 31, 2025 indicates that Fidelity Concord Street Trust-Fidelity Extended Market Index Fund owns about 6.28 shares. This amounts to just over 0.06 percent of the company’s overall shares, with a $3884.0 market value. The same data shows that the other fund manager holds slightly less at 5.76, or about 0.05% of the stock, which is worth about $3567.0.
